Duarte Vieira E Brito, Jose Alberto Pereira, Ana Maria Ferreira, Mario Lourenço, Ricardo Godinho, Bruno Pereira, Pedro Peralta, Paulo Conceiçao, Mario Reis, Carlos Rabaça
{"title":"前列腺癌抢救性冷冻疗法","authors":"Duarte Vieira E Brito, Jose Alberto Pereira, Ana Maria Ferreira, Mario Lourenço, Ricardo Godinho, Bruno Pereira, Pedro Peralta, Paulo Conceiçao, Mario Reis, Carlos Rabaça","doi":"10.4081/aiua.2023.11897","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Most men diagnosed with prostate cancer will be candidates for active treatment and 20 to 50% of patients treated with organ preserving strategies recur within the prostate. Optimal treatment of recurrence is controversial. Prostate cryosurgery has been increasingly used as primary, recurrence and focal treatment for prostate cancer.</p><p><strong>Methods: </strong>We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.</p><p><strong>Results: </strong>Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.</p><p><strong>Conclusions: </strong>Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.</p>","PeriodicalId":46900,"journal":{"name":"Archivio Italiano di Urologia e Andrologia","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Salvage cryotherapy for prostate cancer.\",\"authors\":\"Duarte Vieira E Brito, Jose Alberto Pereira, Ana Maria Ferreira, Mario Lourenço, Ricardo Godinho, Bruno Pereira, Pedro Peralta, Paulo Conceiçao, Mario Reis, Carlos Rabaça\",\"doi\":\"10.4081/aiua.2023.11897\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Most men diagnosed with prostate cancer will be candidates for active treatment and 20 to 50% of patients treated with organ preserving strategies recur within the prostate. Optimal treatment of recurrence is controversial. Prostate cryosurgery has been increasingly used as primary, recurrence and focal treatment for prostate cancer.</p><p><strong>Methods: </strong>We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.</p><p><strong>Results: </strong>Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.</p><p><strong>Conclusions: </strong>Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.</p>\",\"PeriodicalId\":46900,\"journal\":{\"name\":\"Archivio Italiano di Urologia e Andrologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archivio Italiano di Urologia e Andrologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4081/aiua.2023.11897\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivio Italiano di Urologia e Andrologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/aiua.2023.11897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Background: Most men diagnosed with prostate cancer will be candidates for active treatment and 20 to 50% of patients treated with organ preserving strategies recur within the prostate. Optimal treatment of recurrence is controversial. Prostate cryosurgery has been increasingly used as primary, recurrence and focal treatment for prostate cancer.
Methods: We analysed 55 patients submitted to cryotherapy as salvage treatment after recurrence.
Results: Study population presented with a mean age of 70.9 ± 6.2 years, mean initial PSA of 7.6 ng/ml and average prostate volume by ultrasound of 43.2 ± 14.7 grams. Mean follow-up was of 18.0 months. Biochemical free survival at one year of follow-up was of 85%.
Conclusions: Cryotherapy can be an effective and safe treatment for recurrence after primary curative treatment failure.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
